Cinnatropin somatropin 10mg/1.5ml Injection

 8,000

Cinnatropin somatropin 10mg/1.5ml Injection is a prescription medication containing recombinant human growth hormone (somatropin) used to treat growth disorders and growth hormone deficiency in children and adults. It is manufactured by CinnaGen and is available as a ready-to-use solution in a pre-filled pen.

Collection

Key Information

  • Active Ingredient: Somatropin (recombinant human growth hormone).
  • Strength: 10 mg of somatropin in 1.5 ml of solution.
  • Manufacturer: CinnaGen.
  • Administration: Subcutaneous injection (usually into the thigh, buttocks, or abdomen), with the injection site rotated to prevent skin problems. It is administered daily or as directed by a healthcare professional.
  • Legal Status: Available by prescription only.

Indications for Use

CinnaTrophin is indicated for the treatment of various conditions, including:

  • Growth failure in children due to inadequate secretion of endogenous growth hormone (GH).
  • Short stature associated with specific genetic conditions like Turner syndrome, Noonan syndrome, and Prader-Willi syndrome.
  • Short stature in children born small for gestational age (SGA) who fail to show catch-up growth by a certain age.
  • Growth failure in pediatric patients with chronic renal insufficiency.
  • Idiopathic Short Stature (ISS) in children.
  • Adults with growth hormone deficiency (either childhood-onset or adult-onset).

Common Side Effects

Possible side effects include:

  • Injection site reactions (pain, redness, itching).
  • Headache.
  • Joint or muscle pain.
  • Swelling of hands or feet due to fluid retention (edema).
  • Numbness or tingling sensation (carpal tunnel syndrome).
  • Cold or flu-like symptoms.

Important Safety Information and Precautions

  • Medical Supervision: The medication must be used under the guidance and prescription of a qualified healthcare professional. Do not self-administer without proper medical guidance.
  • Contraindications: CinnaTrophin should not be used in patients with an active malignancy (cancer) or certain critical illnesses following surgery or trauma. It is also contraindicated in children with Prader-Willi syndrome who are severely obese or have severe breathing problems.
  • Monitoring: Regular monitoring of blood sugar levels and growth progress is important during treatment. Patients should be evaluated for conditions like scoliosis, slipped capital femoral epiphyses, and intracranial hypertension.
Consult a doctor for the correct diagnosis, dosage, and administration instructions based on individual health needs.

Related Products

CA ATRA 10mg tretinoin soft gelatin capsule

Ca Atra 10 mg (Tretinoin) Soft Gelatin Capsules

 10,000

rebopag 25 mg tablets

Rebopag 25mg – Eltrombopag Tablets

 18,000